Dialog

Dialog, from Clarivate, is a powerful medical literature research solution designed to simplify the research process for organizations that rely on peer-reviewed content to inform critical business decisions. It is purpose-built for life sciences and healthcare professionals, including those working in pharmacovigilance, drug safety, and research and development, who require reliable, high-quality scientific information.

By providing access to peer-reviewed content databases sourced from the world's most trusted and authoritative publishers, Dialog enables researchers to efficiently search, retrieve, and analyse the scientific literature they need to support evidence-based decision-making across the drug development and safety lifecycle.

Core Capabilities

• Access to peer-reviewed content databases drawn from the world's most reliable and authoritative sources
• Comprehensive search functionality designed to support complex, high-precision literature queries
• Support for pharmacovigilance and drug safety workflows requiring thorough and systematic literature review
• Designed to meet the needs of research and development teams seeking to stay current with scientific advances

Who Dialog Is For

• Life sciences and healthcare organisations that depend on peer-reviewed evidence to guide business and regulatory decisions
• Pharmacovigilance and drug safety teams conducting ongoing medical literature monitoring
• Research and development professionals requiring broad and deep access to scientific literature
• Organizations seeking to streamline and standardise their literature review processes

Dialog is part of the broader Clarivate portfolio of research and intelligence solutions, which spans academia, government, life sciences, healthcare, and intellectual property. It integrates within an ecosystem of trusted Clarivate platforms, supporting organisations that require consistent, scalable access to the scientific literature underpinning their operations.